CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Other disposition Chief Executive Officer disposed of 1,137,862 shares (other)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 4 Grant or award SVP, Controller & CAO acquired 45,868 shares (grant or award)
- 4 Shares withheld for taxes EVP, US Pharma gave up 17,578 shares (to pay taxes)
- 4 Planned sale EVP, General Counsel sold 8,388 shares at $5.95 ($49,909)
- 4 Shares withheld for taxes EVP, CFO gave up 35,977 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 116,502 shares (to pay taxes)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Chief Executive Officer acquired 1,137,862 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 137,922 shares (grant or award)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation · Other events
- 4 Grant or award Director acquired 8,992 shares (grant or award)
- 4 Grant or award Director acquired 4,586 shares (grant or award)
- 4 Grant or award Director acquired 989 shares (grant or award)
Page 3 of 121 · 2,419 filings